Crescent Biopharma CBIO
NASDAQ CBIO
$13.17 +0.10 (+0.77%)
At close: Oct 21, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Preferred Shares (2025 - 2026)

Updated

Crescent Biopharma (CBIO) reported Preferred Shares of $4 million for Q2 2026, unchanged from $4 million a year earlier and unchanged from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Preferred Shares (2025 - 2026) Analysis & Trends

Dating back to Q2 2025, Crescent Biopharma's Preferred Shares record includes 5 quarters.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $4 million (Q1 2026), $4 million (Q4 2025) and $4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Crescent Biopharma 401.19 Mn -306.10 Mn - 4.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00 Mn
Mar 31, 2026 4.00 Mn
Dec 31, 2025 4.00 Mn
Sep 30, 2025 4.00 Mn
Jun 30, 2025 4.00 Mn
API Access

Crescent Biopharma Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=CBIO&period=max&api_key=YOUR_API_KEY